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Sir,
We present a 35-year-old male
patient with 10 years’ history of
episodic cluster headache (3–4
attacks per day, previously treated
with methysergide, lithium and oxy-
gen without significant benefit).
Therapy with verapamil 240 mg/day
reduced the frequency of attacks (2–3
per day). After increasing the dose of
verapamil to 360 mg/day the patient
presented hypotension (75/40 mmHg)
and serious bradycardia (HR 32/min),
which required the implant of a tem-
porary ventricular non-sequential
pacemaker. Once the critical period
had passed, the blood pressure nor-
malised; after the electrophysiology
study found normal results, it was
possible to remove the pacemaker.
Before starting verapamil therapy,
cardiac examination and 24-h ECG
recording were normal.
In the last 7 years, we have been
observing four patients treated with
verapamil for episodic cluster
headache that have referred hypoten-
sion and serious bradycardia. The
patients have not presented any con-
traindication to prophylactic therapy
with verapamil. Verapamil is a calci-
um channel blocker and its common
adverse effects include constipation,
dizziness, nausea, bradycardia and
hypotension. It is widely used as a
first-line prophylactic drug for cluster
headache at doses starting at 360 mg
[1, 2]. Patients with cluster headache
present an increase in sympathetic
tone before the attack of a headache.
This “sympathetic storm” could cause
short but hazardous periods of
arrhythmia [3]. On the contrary, a
parasympathetic overactivity with
consequent bradycardia is present
during the attack [4, 5]. Verapamil
therapy prevents episodic cluster
headache but it requires a strict con-
trol of blood pressure and heart rate,
because an overlap between the
effects of verapamil and the effects of
the parasympathetic overactivity
characterising the attack of cluster
headache that could cause serious
hypotension and bradycardia can be
verified [6].
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